PureTech Health plc (NASDAQ:PRTC – Get Free Report)’s share price gapped up prior to trading on Tuesday . The stock had previously closed at $21.35, but opened at $22.83. PureTech Health shares last traded at $23.00, with a volume of 891 shares changing hands.
PureTech Health Trading Up 7.6 %
The company’s 50-day moving average is $24.53 and its 200-day moving average is $26.02.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. purchased a new position in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund purchased 6,900 shares of the company’s stock, valued at approximately $197,000. Institutional investors and hedge funds own 0.04% of the company’s stock.
PureTech Health Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- Why is the Ex-Dividend Date Significant to Investors?
- Buy On Holdings Stock Before the Market Catches Its Second Wind?
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 High-Potential Stocks That Could Turn Into Multi-Baggers
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- CEO Swap: Starbucks Surges 22% on Hiring New CEO From Chipotle
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
